BACKGROUND The existence of stem/progenitor cells in the endometrium was postulated
many years ago, but the first functional evidence was only published in 2004. The …

Stem cell research has expanded at an exponential rate, but its therapeutic applications
have progressed much more slowly. Currently, the research focuses on understanding …

Background The human endometrium in premenopausal women is an active site of
physiological angiogenesis, with regenerative cells present, suggesting that the …

Dysregulation of angiogenesis is a common feature of many disease processes. Vascular
remodeling is believed to depend on the participation of endothelial progenitor cells, but the …

The hemangioblast is a progenitor cell with the capacity to give rise to both hematopoietic
and endothelial progenitors. Currently, the regulatory mechanisms underlying …

During development, hematopoiesis and neovascularization are closely linked to each other
via a common bipotent stem cell called the hemangioblast that gives rise to both …

It has been documented that the uterus plays a key cardio-protective role in pre-menopausal
women, which is supported by uterine cell therapy, to preserve cardiac functioning post …

More than a century ago, several embryologists described sites of hematopoietic activity in
the vascular wall of mid-gestation vertebrate embryos, and postulated the transient …

Clinical evidence suggests that the prevalence of cardiac disease is lower in
premenopausal women compared to postmenopausal women and men. Although multiple …

Stem cell transplantation is nearly available for clinical application in the treatment of
ischaemic heart disease (IHD), where it may be joined traditional methods (intervention and …